On June 12, 2025, Solid Biosciences Inc. announced that shareholders approved several key amendments, including increasing authorized shares from 120M to 240M and adding 9M shares to the 2020 Equity Incentive Plan. The meeting also saw the election of two directors and the ratification of its accounting firm for 2025.